Celltrion
068270.KS
#803
Rank
NZ$50.04 B
Marketcap
NZ$228.76
Share price
6.00%
Change (1 day)
8.17%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.25. In 2024 the company made an earnings per share (EPS) of NZ$2.31 a decrease over its 2023 EPS that were of NZ$4.57.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$3.2239.84%
2024NZ$2.31-49.57%
2023NZ$4.57-2.08%
2022NZ$4.67-11.72%
2021NZ$5.292.03%
2020NZ$5.1882.8%
2019NZ$2.8418.31%
2018NZ$2.40-36.33%
2017NZ$3.76161.25%
2016NZ$1.442.86%
2015NZ$1.4017.84%
2014NZ$1.195.87%
2013NZ$1.12-70.85%
2012NZ$3.85134.09%
2011NZ$1.6543.59%
2010NZ$1.1574.49%
2009NZ$0.66317.8%
2008NZ$0.16-71.7%
2007NZ$0.56